Abstract
Blood pressure (BP) is traditionally assessed, for centuries, at the brachial artery by cuff-based sphygmomanometric techniques. Technological and methodological innovations as well as emerging new findings from clinical studies and trials now provoke a re-consideration of traditional strategies for BP management. The existing knowledge regarding the occurring changes of BP over time (temporal variability) and the evident differences of BP levels between central and peripheral arteries (spatial variability) now pilots the progress in current therapeutic and diagnostic (“theranostic”) concepts and practices in hypertension. This special issue of Current Pharmaceutical Design covers current and intriguing topics regarding the technological, physiological, diagnostic, therapeutic and prognostic aspects of “spatio-temporal” assessment of BP variations. Moreover an in-depth analysis of other topics such as antihypertensive drugs metabolism and polypharmacy at the elderly are included.
Keywords: Central blood pressure, pulse pressure amplification, blood pressure variability, ABPM, chronotherapy, hypertension, circadian rhythm.
Current Pharmaceutical Design
Title:Editorial (Thematic Issue: New Technological and Clinical Trends in Blood Pressure Theranostics: Is it Time to Consider a Spatio-Temporal Approach?)
Volume: 21 Issue: 6
Author(s): Theodore G. Papaioannou, Manolis Vavuranakis, Christodoulos Stefanadis and Dimitris Tousoulis
Affiliation:
Keywords: Central blood pressure, pulse pressure amplification, blood pressure variability, ABPM, chronotherapy, hypertension, circadian rhythm.
Abstract: Blood pressure (BP) is traditionally assessed, for centuries, at the brachial artery by cuff-based sphygmomanometric techniques. Technological and methodological innovations as well as emerging new findings from clinical studies and trials now provoke a re-consideration of traditional strategies for BP management. The existing knowledge regarding the occurring changes of BP over time (temporal variability) and the evident differences of BP levels between central and peripheral arteries (spatial variability) now pilots the progress in current therapeutic and diagnostic (“theranostic”) concepts and practices in hypertension. This special issue of Current Pharmaceutical Design covers current and intriguing topics regarding the technological, physiological, diagnostic, therapeutic and prognostic aspects of “spatio-temporal” assessment of BP variations. Moreover an in-depth analysis of other topics such as antihypertensive drugs metabolism and polypharmacy at the elderly are included.
Export Options
About this article
Cite this article as:
Papaioannou G. Theodore, Vavuranakis Manolis, Stefanadis Christodoulos and Tousoulis Dimitris, Editorial (Thematic Issue: New Technological and Clinical Trends in Blood Pressure Theranostics: Is it Time to Consider a Spatio-Temporal Approach?), Current Pharmaceutical Design 2015; 21 (6) . https://dx.doi.org/10.2174/1381612820666141024154427
DOI https://dx.doi.org/10.2174/1381612820666141024154427 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cigarette Smoking and Hypertension
Current Pharmaceutical Design Targeting Nitrosative Stress for Neurovascular Protection: New Implications in Brain Diseases
Current Drug Targets Low Molecular Weight Heparins and Glomerular Filtration Rate: A Report to be Considered
Current Vascular Pharmacology Atherosclerosis, Degenerative Aortic Stenosis and Statins
Current Drug Targets Nitric Oxide in Normal and Preeclamptic Pregnancy
Current Pharmaceutical Biotechnology Mitochondria-Targeted Antioxidant Peptide SS31 Protects the Retinas of Diabetic Rats
Current Molecular Medicine Molecular Markers of Cardiovascular Damage in Hypertension
Current Pharmaceutical Design Anticoagulant Therapy in Pregnant Patients with Metabolic Syndrome: A Review
Current Pharmaceutical Biotechnology C-type Natriuretic Peptide (CNP): Cardiovascular Roles and Potential as a Therapeutic Target
Current Pharmaceutical Design Genetic and Non-Genetic Determinants of the Pharmacological Activity of Statins
Current Drug Metabolism Resveratrol as a Potential Therapeutic Candidate for the Treatment and Management of Alzheimer's Disease
Current Topics in Medicinal Chemistry Free Radicals and Antioxidants: How to Reestablish Redox Homeostasis in Chronic Diseases?
Current Medicinal Chemistry The Calcium-Sensing Receptor as a Regulator of Cellular Fate in Normal and Pathological Conditions
Current Molecular Medicine CRP Pro-inflammatory Signalling in Atherosclerosis: Myth or Reality?
Current Signal Transduction Therapy Exogenous Heparin-Derivative Affords Protection Against Lipid Anomalies and Apoptotic DNA Damage in Experimental Atherogenesis
Vascular Disease Prevention (Discontinued) Controversies in Pharmacological Treatment of Inflammatory Component of Macular Edema
Current Pharmaceutical Design Oxidized LDL Antibodies in Treatment and Risk Assessment of Atherosclerosis and Associated Cardiovascular Disease
Current Pharmaceutical Design The Ultrasonographic Diagnosis of Polycystic Ovary Syndrome
Current Medical Imaging Reactive Oxygen Species, Vascular Disease and Cardiovascular Surgery
Current Vascular Pharmacology Purines as Neurotransmitters and Neuromodulators in Blood Vessels
Current Vascular Pharmacology